MeSH term | MeSH ID | Detail |
---|---|---|
Cholestasis | D002779 | 23 associated lipids |
Xanthomatosis, Cerebrotendinous | D019294 | 14 associated lipids |
7alpha-hydroxy-4-cholesten-3-one is a lipid of Sterol Lipids (ST) class. The related lipids are Steroids and Cholestenones.
To understand associated biological information of 7alpha-Hydroxy-4-cholesten-3-one, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 7alpha-Hydroxy-4-cholesten-3-one
MeSH term | MeSH ID | Detail |
---|---|---|
Cholestasis | D002779 | 23 associated lipids |
Xanthomatosis, Cerebrotendinous | D019294 | 14 associated lipids |
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid: | ||||
Yoshida T et al. | Plasma levels of mevalonate and 7alpha-hydroxy-4-cholesten-3-one in chronic liver disease. | 1999 | J. Gastroenterol. Hepatol. | pmid:10029296 |
Naoumova RP et al. | Effect of inhibiting HMG-CoA reductase on 7 alpha-hydroxy-4-cholesten-3-one, a marker of bile acid synthesis: contrasting findings in patients with and without prior up-regulation of the latter pathway. | 1999 | Eur. J. Clin. Invest. | pmid:10354197 |
Rust C et al. | Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man. | 2000 | Eur. J. Clin. Invest. | pmid:10651838 |
Honda A et al. | Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX. | 2001 | J. Lipid Res. | pmid:11181760 |
Einarsson C et al. | Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects. | 2001 | Hepatology | pmid:11343248 |
O'Neill FH et al. | Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolemia. | 2001 | Arterioscler. Thromb. Vasc. Biol. | pmid:11348882 |
Tatidis L et al. | Cholesterol catabolism in patients with acute myelogenous leukemia and hypocholesterolemia: suppressed levels of a circulating marker for bile acid synthesis. | 2001 | Cancer Lett. | pmid:11463495 |
Gälman C et al. | Prolonged stimulation of the adrenals by corticotropin suppresses hepatic low-density lipoprotein and high-density lipoprotein receptors and increases plasma cholesterol. | 2002 | Endocrinology | pmid:11956163 |
Maeda Y et al. | A comparative study of the conversion of 7-hydroxycholesterol in rabbit, guinea pig, rat, hamster, and chicken. | 2002 | Steroids | pmid:12117617 |